On 13 April, ELIXIR and ELIXIR Netherlands held an Innovation and SME Forum focusing on machine learning and artificial intelligence (AI) in health research with more than 60 participants from industry and academia.
Read the news
ELIXIR Director announces departure at end of the current Scientific Programme
We would hereby like to inform you that Niklas Blomberg, Director of ELIXIR since its formation in 2013, announced this week that he will be stepping down from his role at the end of 2023, coinciding with the completion of the 2019-23 Scientific Programme. Niklas leaves to take up a new opportunity, having steered ELIXIR through two successive Scientific Programmes and multiple major EU-funded projects.
Expressions of Interest for Science Priority Area co-Leads
This years EBIF will focus on "Trusted research environment for sensitive data in the life sciences". The programme features a variety of presentations from industry and academia, offering the participants a chance to learn more about ELIXIR, relevant initiatives and research breakthroughs and outcomes.
On 23-27 July 2023, ELIXIR was in Lyon for ISMB/ECCB 2023 with more than a thousand bioinformaticians around the world. As a sponsor of the event, ELIXIR had a dedicated booth and hosted a track programme with NIH ODSS on BioData Ecosystems.
Read the news
You can find key communications resources on the ELIXIR Intranet:
Please remember to upload your slides or posters presented during ELIXIR All Hands 2023 on the F1000 ELIXIR Gateway
A recently published book, Artificial Intelligence for Science, features three chapters with ELIXIR authors:
Please share the vacancy information with your networks:
Twitter
LinkedIn
View vacancy announcement
General Report from the ELIXIR SAB TC, June 2023
We would hereby like to share with you the General Report from the ELIXIR Scientific Advisory Board (SAB) TC, which took place on 21 June. The Report, which includes the SAB's recommendations from topics discussed at the meeting will be presented to the ELIXIR Board for its consideration at its next meeting, which will take place from 30-31 October in Barcelona, Spain.
Publicly funded research infrastructures, such as ELIXIR, enable the creation of scientific knowledge and drive innovation. Due to both the substantial public investment necessary for their creation and maintenance, and the significance of their contribution to the scientific community, research infrastructures have a role to play in public policy.
Read more